Literature DB >> 16679337

Exposure to antineoplastic drugs outside the hospital environment.

T Meijster1, W Fransman, R Veldhof, H Kromhout.   

Abstract

OBJECTIVES: The objectives were (i) to identify occupational populations outside hospitals working with antineoplastic drugs, (ii) to determine the size of the populations 'at risk', (iii) to identify major determinants and routes of exposure outside hospitals and (iv) to estimate exposure levels and frequencies relative to levels found in hospitals.
METHODS: The survey consisted of two phases; (i) identification of activities with potential exposure to antineoplastic drugs by literature review, interviews, questionnaires and workplace visits, (ii) exploratory measurements of exposure and surface contamination in selected sectors.
RESULTS: Eight sectors were identified with potential exposure to antineoplastic drugs: pharmaceutical industry, pharmacies, universities, veterinary medicine, nursing homes, home care, laundry facilities, and waste treatment. Four sectors were of primary concern: veterinary medicine, home care, nursing homes and industrial laundries. The populations potentially exposed in these sectors vary considerably (from several tens to thousands of workers), as do their levels of exposure. Exposure measurements collected in the veterinary medicine sector showed that workers are indeed exposed to antineoplastic drugs and, in some cases (on gloves after administration), levels were 15 times higher than levels measured during administration in hospitals. Workers sorting contaminated hospital laundry in industrial laundry facilities were exposed to antineoplastic drugs through inhalation. For the home care and nursing homes sectors the highest exposure levels were found when cleaning toilets and washing treated patients. These two sectors are expected to have the largest exposed population (5,000-10,000 individuals).
CONCLUSIONS: This study has resulted in a comprehensive overview of populations with potential exposure to antineoplastic drugs. Exposure levels can potentially be high compared with the hospital environment, because exposure routes are complex and awareness of the hazard (and therefore use of protective measures) is low. The number of individuals outside hospitals in The Netherlands exposed to antineoplastic drugs is estimated to be between 5,000 and 15,000.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16679337     DOI: 10.1093/annhyg/mel023

Source DB:  PubMed          Journal:  Ann Occup Hyg        ISSN: 0003-4878


  7 in total

1.  Inhalation and dermal exposure to eight antineoplastic drugs in an industrial laundry facility.

Authors:  Wouter Fransman; Daan Huizer; Jochen Tuerk; Hans Kromhout
Journal:  Int Arch Occup Environ Health       Date:  2006-10-05       Impact factor: 3.015

Review 2.  Environmental monitoring by surface sampling for cytotoxics: a review.

Authors:  Petit Marie; Curti Christophe; Roche Manon; Montana Marc; Bornet Charleric; Vanelle Patrice
Journal:  Environ Monit Assess       Date:  2017-01-06       Impact factor: 2.513

Review 3.  Review of hazards to female reproductive health in veterinary practice.

Authors:  Joni M Scheftel; Brigid L Elchos; Carol S Rubin; John A Decker
Journal:  J Am Vet Med Assoc       Date:  2017-04-15       Impact factor: 1.936

4.  Perception, knowledge and protective practices for surgical staff handling antineoplastic drugs during HIPEC and PIPAC.

Authors:  Hubert Benoist; Clarisse Eveno; Sarah Wilson; Nicolas Vigneron; Jean-Marc Guilloit; Rémy Morello; Nicolas Simon; Pascal Odou; Guillaume Saint-Lorant
Journal:  Pleura Peritoneum       Date:  2022-04-13

5.  Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital.

Authors:  M Hedmer; H Tinnerberg; A Axmon; B A G Jönsson
Journal:  Int Arch Occup Environ Health       Date:  2007-12-08       Impact factor: 3.015

6.  Estimating National-Level Exposure to Antineoplastic Agents in the Workplace: CAREX Canada Findings and Future Research Needs.

Authors:  Amy L Hall; Paul A Demers; George Astrakianakis; Calvin Ge; Cheryl E Peters
Journal:  Ann Work Expo Health       Date:  2017-07-01       Impact factor: 2.179

7.  ACVIM small animal consensus statement on safe use of cytotoxic chemotherapeutics in veterinary practice.

Authors:  Annette N Smith; Shawna Klahn; Brenda Phillips; Lisa Parshley; Peter Bennett; Andi Flory; Rosemary Calderon
Journal:  J Vet Intern Med       Date:  2018-03-30       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.